Mangaciclanol’s Phase I trial showed it was well tolerated, with no serious adverse events or clinically significant findings ...

GE HealthCare (Nasdaq: GEHC) today announced the first patient has been dosed in the international, multi-center Phase 2/3 ...

Magnetic resonance imaging (MRI) is indispensable for clinical diagnostics and treatment planning, offering unparalleled soft tissue contrast. However, intrinsic imperfections—stemming from gradient ...

The Graduate Certificate in Magnetic Resonance Imaging (MRI) is available to those who hold both a bachelor’s degree and a primary certification in radiography, nuclear medicine technology, sonography ...

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is being used in oncology as a noninvasive method for measuring properties of the tumor microvasculature. There is potential for DCE-MRI ...

Magnetic resonance enterography (MRE) is a type of medical imaging that uses a magnetic field to view details in the small intestine. Doctors can use this technique to diagnose conditions such as ...

GE HealthCare doses first patient in phase 2/3 LUMINA trial for manganese-based MRI contrast agent, mangaciclanol: Chalfont St Giles,?UK Saturday, April 25, 2026, 12:00 Hrs [IST] ...

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with ...

Magnetic resonance imaging (MRI) is an imaging modality on the basis of the principle of nuclear magnetic resonance. As hydrogen atoms constitute the major share of the human body, it enables the use ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...